Pharmaceutical Technology4 天
Atezolizumab by F. Hoffmann-La Roche for Muscle Invasive Bladder Cancer (MIBC): Likelihood ...
Atezolizumab is under clinical development by F. Hoffmann-La Roche and currently in Phase III for Muscle Invasive Bladder Cancer (MIBC).
Pharmaceutical Technology4 天
Atezolizumab by F. Hoffmann-La Roche for Nasopharyngeal Cancer: Likelihood of Approval
Atezolizumab is under clinical development by F. Hoffmann-La Roche and currently in Phase II for Nasopharyngeal Cancer.